U.S. Venture Partners overview
Stories about U.S. Venture Partners
U.S. Venture Partners holds final closing of twelfth fund
The California firm raised $340 million for its latest vehicle.
USVP racks up $340 mln for 12th fund
U.S. Venture Partners has closed its twelfth fund at $340 million.
Toncheva promoted at USVP, Investor bails on Vision Fund, and a monthly recap of other VCs on the Move
A compilation of personnel moves from the previous four weeks at various firms, including USVP, Next Ventures and SoftBank
U.S. Venture Partners elevates Toncheva
U.S. Venture Partners said Oct. 9 that it promoted Dafina Toncheva to general partner.
Edgewise Therapeutics locks in $50 mln Series B
Boulder, Colorado-based Edgewise Therapeutics, a preclinical company developing small molecule therapies for musculoskeletal diseases, has secured $50 million in Series B financing. Novo Holdings A/S and U.S. Venture Partners led the round.
Human Interest raises $15.4 mln
Human Interest said Aug. 5 that it raised $15.4 million in funding led by U.S. Venture Partners. Participating in the round were Wing VC, Uncork Capital and Slow Ventures. Human Interest, of San Francisco, is an automated 401(k) provider.
Percepto nabs $15 mln Series A
Percepto, a provider of industrial autonomous drone solutions, has raised $15 million in Series A funding. USVP led the round with participation from return backers NHN, Spider Capital and Emerge.
Percepto nabs $15 mln Series A
Percepto, a provider of industrial autonomous drone solutions, has raised $15 million in Series A funding. USVP led the round with participation from return backers NHN, Spider Capital and Emerge.
U.S. Venture Partners contact information
Offices
1460 El Camino Real, Suite 100, Menlo Park, 94025, United StatesContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Mr. Jacques Benkoski | Job titleGeneral Partner | LocationMenlo Park, United States | Email  ----- |
| Mr. Dale Holladay | Job titleChief Financial Officer | LocationMenlo Park, United States | Email ----------- |
| Mr. Matt Garratt | Job titleGeneral Partner | LocationMenlo Park, United States | Email ----------- |
| Mr. Steve Krausz | Job titleGeneral Partner | LocationMenlo Park, United States | Email --------- |
U.S. Venture Partners funds managed
Funds in market: 2
| Fund | Fund size | Open date | Strategy |
|---|---|---|---|
Fund size ----------- | Open dateJul 2026 | Strategy ---------- | |
Fund size ---------- | Open dateOct 2024 | Strategy ----------- | |
Closed funds: 12
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size --------- | Close dateDec 2022 | Strategy ----- | |
Fund size --------- | Close dateJan 2020 | Strategy -------- | |
Fund size ----- | Close dateDec 2015 | Strategy ---------- | |
Stories that mention U.S. Venture Partners
Surgical Safety Technologies lands $15m in Series A financing
Based in Toronto, Surgical Safety Technologies is a medical technology company that engineered the OR Black Box, a platform for improving patient safety.
HeartFlow inks $215m Series F
Bain Capital Life Sciences led the round.
MicroTransponder collects $53m Series E
US Venture Partners led the round.
Hunters scoops up $68m Series C
Hunters, a security operations platform, has raised $68 million in Series C funding.
Clear Ventures unveils new AI-focused investment initiative
Clear Ventures has launched a new investment initiative to fund and support AI startups emerging from academic research institutions.
Data and security platform Hunters locks in $30m Series B
Hunters, a data and security platform, has raised $30 million in Series B funding.
Ribon Therapeutics picks up $65m
Ribon Therapeutics, a clinical stage biotechnology company, has secured $65 million in financing.
Sparrow Pharmaceuticals rings in $50m Series A
Sparrow Pharmaceuticals, an emerging clinical-stage biopharmaceutical company, has raised $50 million in Series A financing.